FDA Clearance Tracker · P230040-S030
Cordella Pulmonary Artery Sensor System
Last checked: Nov 20, 2026Latest source record: Oct 29, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Oct 29, 2026
Approved
Time to decision
251 days
Received Feb 20, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230040-S030
- Device name
- Cordella Pulmonary Artery Sensor System
- Applicant
- Endotronix, Inc.
- Applicant location
- Naperville, IL
- Received
- Feb 20, 2026
- Decided
- Oct 29, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P230040
Device type
- Device type
- System, hemodynamic, implantable (MOM)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
addition of alternate Ethyle Oxide (EO) gas sterilization facility
Source documents
Other decisions for Endotronix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P230040 · Decided Jun 20, 2024 · 190 days after receipt
Device type: System, hemodynamic, implantable (MOM) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.